Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-15

FDA Approved: HYDROXYCHLOROQUINE SULFATE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a generic hydroxychloroquine sulfate product under an Original Application from Rising Pharma Holdings, Inc. for use in treating malaria and ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine sulfate (Hydroxychloroquine sulfate)

Snippet

ORIG AP for HYDROXYCHLOROQUINE SULFATE (HYDROXYCHLOROQUINE SULFATE)